Teva’s Acquisition Of Barr Will Boost Research For Molecules Large And Small
Teva expects to double its R&D capabilities with the acquisition of Barr, executives from both firms said during a July 21 luncheon in New York
Teva expects to double its R&D capabilities with the acquisition of Barr, executives from both firms said during a July 21 luncheon in New York